SENOKOT^® Family
of Remedies

Reduce dose or discontinue use if you experience abdominal pain, griping (cramps or spasms) and/or diarrhea. Do not use in the presence of fecal impaction (a large lump of dry, hard stool that develops in the rectum) and undiagnosed, acute or persistent gastrointestinal complaints (e.g., abdominal pain, nausea, fever or vomiting) as these symptoms can be signs of a potential or existing intestinal blockage or ileus. Consult a healthcare practitioner if symptoms persist or worsen.

Laxatives should not be taken within two hours of another medicine because the desired effect of the other medicine may be reduced. If rectal bleeding or failure to have a bowel movement after use occurs, discontinue therapy and consult a physician, as this may indicate a serious condition. If there has been a sudden change in your bowel movements that persists over a 2-week period, consult a physician before use. Consult a physician prior to use if you are taking thiazide diuretics (drugs used to treat high blood pressure), corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance. Consult a physician prior to use if you have a kidney disorder or are taking cardiac medications such as cardiac glycosides or antiarrhythmic medications. Long-term use of stimulant laxatives should be avoided as it may lead to impaired function of the intestine, dependence on laxatives, dehydration and electrolyte imbalance (including hypokalemia). Concomitant therapy with other drugs or herbal substances known to induce hypokalemia (e.g., diuretics, adrenocorticosteroids and licorice root) may enhance the electrolyte imbalance. Prolonged excessive use or misuse of these products may also result in the development of atonic colon.

Fertility, Pregnancy and Lactation: Consult a physician before use. There are no reports of undesirable or damaging effects during pregnancy or on the fetus associated with senna preparations when used in accordance with the recommended dosage schedule. However, as a consequence of experimental data concerning a genotoxic risk of several anthranoids (e.g. emodin and aloe-emodin), use is not recommended during pregnancy. Small amounts of active metabolites (rhein) are excreted in breast milk. A laxative effect in breast fed babies has not been reported. However, use during breast-feeding is not recommended as there is insufficient data on the excretion of metabolites in breast milk. Drug Interactions: There are no known drug interactions with sennosides.

Symptoms and treatment of overdosage: The major symptoms of overdose or abuse of any stimulant laxative, including those containing senna, are griping pain and severe diarrhea, leading to excessive water loss (dehydration) and possible electrolyte imbalance (hypokalemia). Treatment should be supported with generous amounts of fluid. Electrolytes, especially potassium, should be monitored. This is especially important in the elderly. In case of overdose: Call a Regional Poison Control Centre and/or your physician and/or your local emergency number immediately, or go to your local hospital emergency, even if you do not notice any signs or symptoms. Keep all medicines out of the reach of children.

ACTIVE INGREDIENTS: Each SENOKOT^® tablet contains 8.6 mg standardized sennosides from natural senna.

NON-MEDICINAL INGREDIENTS: Corn starch, magnesium stearate, microcrystalline cellulose.

Store at 15-25°C.

SENOKOT^® Tablets can be found at your local pharmacy and in many popular and convenient stores across Canada. Samples may be available through your family physician.

Please read and follow the information on the label to be sure this product is suitable for you.

Reduce dose or discontinue use if you experience abdominal pain, cramps or spasms and/or diarrhea. Do not use in the presence of fecal impaction (a large lump of dry, hard stool that develops in the rectum); undiagnosed, acute or persistent gastrointestinal complaints (e.g., abdominal pain, nausea, fever or vomiting); appendicitis; inflamed bowel or intestinal blockage. Consult a healthcare practitioner if symptoms continue to occur or worsen. As with all laxatives, do not take for more than one week. If laxatives are needed every day, consult a healthcare practitioner. Long-term use of stimulant laxatives should be avoided. Prolonged excessive use or misuse may precipitate the onset of atonic (non-functioning) colon. If rectal bleeding or failure to have a bowel movement (after use of a laxative) occurs, therapy should be discontinued as it may indicate a more serious condition - consult a physician. If there has been a sudden change in bowel movements that persists over a period of 2 weeks, consult a physician before using a laxative. Consult a healthcare practitioner prior to use if you have a kidney disorder, are pregnant or breastfeeding.

SENOKOT^®•S should not be taken within two hours of another medicine as it may reduce the effectiveness of other medicine. Drugs that may interact with SENOKOT^®•S include: cardiac medications such as cardiac glycosides (drugs that increase the force of contraction of the heart) or antiarrhythmic medications (drugs that restore the normal rhythm of the heart); mineral oil; thiazide diuretics (drugs used to treat high blood pressure), corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance.

Fertility, Pregnancy and Lactation: There are no reports of adverse or damaging effects during pregnancy or on the fetus associated with senna preparations when used in accordance to the recommended dosage schedule. However, as a consequence of experimental data concerning a genotoxic risk of several anthranoids (e.g., emodin and aloe-emodin) use is not recommended during pregnancy. Small amounts of active metabolites (rhein) are excreted in breast milk. A laxative effect in breast fed babies has not been reported. However, use during breastfeeding is not recommended as there is insufficient data on the excretion of metabolites in breast milk.

Overdose: The major symptoms of overdose/abuse of stimulant laxative, including those containing senna, are griping pain and severe diarrhea, leading to excessive water loss (dehydration) and possible electrolyte imbalance (i.e. hypokalemia). In case of overdose: call a Regional Poison Control Centre and/or your physician and/or your local emergency number immediately, or go to your local hospital emergency, even if you do not notice any signs or symptoms.

MEDICINAL INGREDIENTS: Standardized sennosides from senna and docusate sodium.

NON-MEDICINAL INGREDIENTS: cornstarch, D&C Yellow No. 10 Aluminum Lake, FD&C Yellow No. 6 Aluminum Lake, guar gum, lecithin, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, silicon dioxide, sodium benzoate, talc and titanium dioxide.

Store at 15-25°C.

SENOKOT^®•S can be found at your local pharmacy and in many popular and convenient stores across Canada. Samples may be available through your family physician.

Please read and follow the information on the label to be sure this product is suitable for you.

Reduce dose or discontinue use if you experience abdominal pain, griping (cramps or spasms) and/or diarrhea. Do not use in the presence of fecal impaction (a large lump of dry, hard stool that develops in the rectum) and undiagnosed, acute or persistent gastrointestinal complaints (e.g., abdominal pain, nausea, fever or vomiting) as these symptoms can be signs of a potential or existing intestinal blockage or ileus. Consult a healthcare practitioner if symptoms persist or worsen. Hypersensitivity is known to occur, in which case, discontinue use. If rectal bleeding or failure to have a bowel movement occurs, discontinue therapy and consult a physician, as this may indicate a serious condition.

Consult a physician prior to use if you are taking thiazide diuretics (drugs used to treat high blood pressure), corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance. Consult a physician prior to use if you have a kidney disorder or are taking cardiac medications such as cardiac glycosides or antiarrhythmic medications. Long-term use of stimulant laxatives should be avoided as it may lead to impaired function of the intestine, dependence on laxatives, dehydration and electrolyte imbalance (including hypokalemia). Concomitant therapy with other drugs or herbal substances known to induce hypokalemia (e.g., diuretics, adrenocorticosteroids and licorice root) may enhance the electrolyte imbalance. Prolonged excessive use or misuse of these products may also result in the development of atonic colon.

Symptoms and treatment of overdosage: The major symptoms of overdose abuse of any stimulant laxative, including those containing senna, are griping pain and severe diarrhea, leading to excessive water loss (dehydration) and possible electrolyte imbalance (hypokalemia). Treatment should be supported with generous amounts of fluid. Electrolytes, especially potassium, should be monitored. This is especially important in the elderly. In case of overdose: Call a Regional Poison Control Centre and/or your physician and/or your local emergency number immediately, or go to your local hospital emergency, even if you do not notice any signs or symptoms. Keep all medicines out of the reach of children.

ACTIVE INGREDIENTS: Each SENOKOT^® Extra Strength tablet contains 17.2 mg sennosides from natural senna.

NON-MEDICINAL INGREDIENTS: Corn starch, magnesium stearate, microcrystalline cellulose.

Store at 15-25°C.

SENOKOT^® Extra Strength Tablets can be found at your local pharmacy and in many popular and convenient stores across Canada. Samples may be available through your family physician.

Please read and follow the information on the label to be sure this product is suitable for you.

Reduce dose or discontinue use if you experience abdominal pain, griping (cramps or spasms) and/or diarrhea. Do not use in the presence of fecal impaction (a large lump of dry, hard stool that develops in the rectum) and undiagnosed, acute or persistent gastrointestinal complaints (e.g., abdominal pain, nausea, fever or vomiting) as these symptoms can be signs of a potential or existing intestinal blockage or ileus. Consult a healthcare practitioner if symptoms persist or worsen.

Laxatives should not be taken within two hours of another medicine because the desired effect of the other medicine may be reduced. If rectal bleeding or failure to have a bowel movement after use occurs, discontinue therapy and consult a physician, as this may indicate a serious condition. If there has been a sudden change in your bowel movements that persists over a 2-week period, consult a physician before use. Consult a physician prior to use if you are taking thiazide diuretics (drugs used to treat high blood pressure), corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance. Consult a physician prior to use if you have a kidney disorder or are taking cardiac medications such as cardiac glycosides or antiarrhythmic medications. Long-term use of stimulant laxatives should be avoided as it may lead to impaired function of the intestine, dependence on laxatives, dehydration and electrolyte imbalance (including hypokalemia). Concomitant therapy with other drugs or herbal substances known to induce hypokalemia (e.g., diuretics, adrenocorticosteroids and licorice root) may enhance the electrolyte imbalance. Prolonged excessive use or misuse of these products may also result in the development of atonic colon.

Fertility, Pregnancy and Lactation: Consult a physician before use. There are no reports of undesirable or damaging effects during pregnancy or on the fetus associated with senna preparations when used in accordance with the recommended dosage schedule. However, as a consequence of experimental data concerning a genotoxic risk of several anthranoids (e.g. emodin and aloe-emodin), use is not recommended during pregnancy. Small amounts of active metabolites (rhein) are excreted in breast milk. A laxative effect in breast fed babies has not been reported. However, use during breast-feeding is not recommended as there is insufficient data on the excretion of metabolites in breast milk. Drug Interactions: There are no known drug interactions with sennosides.

Symptoms and treatment of overdosage: The major symptoms of overdose or abuse of any stimulant laxative, including those containing senna, are griping pain and severe diarrhea, leading to excessive water loss (dehydration) and possible electrolyte imbalance (hypokalemia).

Treatment should be supported with generous amounts of fluid. Electrolytes, especially potassium, should be monitored. This is especially important in the elderly. In case of overdose: Call a Regional Poison Control Centre and/or your physician and/or your local emergency number immediately, or go to your local hospital emergency, even if you do not notice any signs or symptoms. Keep all medicines out of the reach of children.

ACTIVE INGREDIENTS: Each SENOKOT^® for Women tablet contains 8.6 mg standardized sennosides from natural senna.

NON-MEDICINAL INGREDIENTS: Corn starch, glycerin, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, iron oxide red, titanium dioxide.

Store at 15-25°C.

SENOKOT^® for Women Laxative Tablets can be found at your local pharmacy and in many popular and convenient stores across Canada. Samples may be available through your family physician.

Please read and follow the information on the label to be sure this product is suitable for you.

Reduce dose or discontinue use if you experience abdominal pain, griping (cramps or spasms) and/or diarrhea. Do not use in the presence of fecal impaction (a large lump of dry, hard stool that develops in the rectum) and undiagnosed, acute or persistent gastrointestinal complaints (e.g., abdominal pain, nausea, fever or vomiting) as these symptoms can be signs of a potential or existing intestinal blockage or ileus. Consult a healthcare practitioner if symptoms persist or worsen. Laxatives should not be taken within two hours of another medicine because the desired effect of the other medicine may be reduced. If rectal bleeding or failure to have a bowel movement after use occurs, discontinue therapy and consult a physician, as this may indicate a serious condition. If there has been a sudden change in your bowel movements that persists over a 2-week period, consult a physician before use.

Consult a physician prior to use if you are taking thiazide diuretics (drugs used to treat high blood pressure), corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance. Consult a physician prior to use if you have a kidney disorder or are taking cardiac medications such as cardiac glycosides or antiarrhythmic medications. Long term use of stimulant laxatives should be avoided as it may lead to impaired function of the intestine, dependence on laxatives, dehydration and electrolyte imbalance (including hypokalemia). Concomitant therapy with other drugs or herbal substances known to induce hypokalemia (e.g., diuretics, adrenocorticosteroids and licorice root) may enhance the electrolyte imbalance.

Prolonged excessive use or misuse of these products may also result in the development of atonic colon. For patients on a sodium-restricted diet, there is a very small amount of sodium in SENOKOT^® Syrup. See Non-Medicinal Ingredients on label. If you are pregnant or breast-feeding, consult a healthcare practitioner before use. Drug Interactions: There are no known drug interactions with sennosides.

Symptoms and treatment of overdosage: The major symptoms of overdose abuse of any stimulant laxative including those containing senna are griping pain and severe diarrhea, leading to excessive water loss (dehydration) and possible electrolyte imbalance (hypokalemia). Treatment should be supported with generous amounts of fluid. Electrolytes, especially potassium, should be monitored. This is especially important in the elderly. In case of overdose: Call a Regional Poison Control Centre and/or your physician and/or your local emergency number immediately, or go to your local hospital emergency, even if you do not notice any signs or symptoms. Keep all medicines out of the reach of children.

ACTIVE INGREDIENTS: Each mL of SENOKOT^® syrup contains 1.7 mg standardized sennosides from a natural source.

NON-MEDICINAL INGREDIENTS: Chocolate flavour, citric acid monohydrate, peppermint flavour, sodium citrate dihydrate, sodium metabisulfite, sodium methylparaben, sodium propylparaben, sorbitol (3 g/100 mL equivalent to 7.8 kcal), sucralose (110 mg/100 mL), water, xanthan gum.

Store at 15-25°C.

SENOKOT^® Syrup can be found at your local pharmacy and in many popular and convenient stores across Canada. Samples may be available through your family physician.

Please read and follow the information on the label to be sure this product is suitable for you.

Consult a healthcare practitioner if symptoms persist or worsen.